The Multi-Stage Malaria Vaccine Consortium (MMVC) seeks applications for three four-year PhD fellowships supported by the European & Developing Countries Clinical Trials Partnership (EDCTP). MMVC offers training and excellent research opportunities for outstanding African PhD students in a vibrant and stimulating scientific environment. Fellowships are open to all African scientists wishing to pursue a career in malaria research and vaccinology. MMVC Fellowships may be held at one of the MMVC African partner institutions in Burkina Faso, Kenya, Sierra Leone, Tanzania, The Gambia but applications are open to others who meet the required eligibility criteria working outside these institutions.
Applicants must be African nationals, and have an intention to pursue a long-term career in malaria research and/or vaccinology. Closing date 15 March 2019, 17:00 GMT. More details here.
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA. Mol Ther Methods Clin Dev, 12, pp. 32-46. Article
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults. J Infect. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Prof Paul Brett: Development of Subunit Vaccines for Immunization Against Melioidosis , 25/Feb/2019 11:30